MedPath

Outcome of Patients After a Negative Oral Challenge to Amoxicillin

Completed
Conditions
Negative Challenge to Amoxicillin
Registration Number
NCT04922034
Lead Sponsor
University Hospital, Angers
Brief Summary

This study aims to evaluate the outcome of patients who had a negative oral challenge to Amoxicillin

Detailed Description

This is a prospective, single-center, non-interventional study of patients with negative Amoxicillin oral challenge performed at Angers University Hospital between 2017 and 2019.

An information letter indicating the purpose of the study is sent to eligible patients. If they do not object, patients are contacted by telephone to answer the questionnaire. This questionnaire concerns the reintroduction of penicillins at home after the challenge.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
190
Inclusion Criteria
  • Patients whith a negative challenge to Amoxicillin in the Allergology Department of the CHU of Angers between 2017 and 2019.
  • Major patients.
Read More
Exclusion Criteria
  • Poor comprehension of the French language or cognitive disorders affecting the reliability of the questionnaire
  • Person objecting to participate in this research and to the processing of their medical data
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Resumption of Amoxicillin after a negative oral challenge to AmoxicillinOral challenge test oxxuring between 2017 and 2019, and follow-up until the day of the call

The main objective is to know if patients who had a negative test for reintroduction of Amoxicillin, have resumed this molecule afterwards.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU

🇫🇷

Angers, Maine Et Loire, France

© Copyright 2025. All Rights Reserved by MedPath